Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors.
暂无分享,去创建一个
J. Schellens | E. Voest | J. Drevs | W. Fiedler | C. Unger | H. Blum | C. V. van Herpen | J. D. de Bono | M. Langenberg | A. Fielding | K. Hoekman | F. Le Maulf | J. Robertson